In immune regulation, the role of immune checkpoint molecules carried by iEVs is controversial: while they enhance immunosuppressive functions in tumors and regulatory immune cells, they may also counteract PD-1/PD-L1 inhibition to improve anti-tumor immunity. Here, CD274 is linked to neoplasm.